KR950023404A - 5-히드록시메틸-2-푸르푸랄을 함유하는 비(b)형 간염 치료제 - Google Patents
5-히드록시메틸-2-푸르푸랄을 함유하는 비(b)형 간염 치료제 Download PDFInfo
- Publication number
- KR950023404A KR950023404A KR1019940001240A KR19940001240A KR950023404A KR 950023404 A KR950023404 A KR 950023404A KR 1019940001240 A KR1019940001240 A KR 1019940001240A KR 19940001240 A KR19940001240 A KR 19940001240A KR 950023404 A KR950023404 A KR 950023404A
- Authority
- KR
- South Korea
- Prior art keywords
- hepatitis
- furfural
- hydroxymethyl
- therapeutics containing
- hepatitis therapeutics
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
본 발명은 B형 간염 표면항원 생성 억제효과 및 B형 간염 바이러스의 DNA 생성 억제 효과를 나타내는 5-히드록시메틸-2-푸르푸랄을 활성성분으로 포함하는 B형 간염 치료제를 제공한다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 5-히드록시메틸-2-푸르푸랄과 표준품인 Ara-AMP를 비교정량 PCR방법으로 B형 간염 바이러스 DNA 생성 억제 정도를 비교 분석한 결과를 나타낸 것이다.
Claims (2)
- 5-히드로시메틸-2-푸르푸랄을 활성성분으로 포함하는 B형 간염 치료제.
- 제1항에 있어서, 5-히드록시메틸-2-푸르푸랄이 천연약제 유래, 식품 유래 또는 화학합성된 것인 B형 간염 치료제.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019940001240A KR100285586B1 (ko) | 1994-01-25 | 1994-01-25 | 5-하드록시메틸-2-푸르푸랄을 함유하는 비형 간염 치료제 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019940001240A KR100285586B1 (ko) | 1994-01-25 | 1994-01-25 | 5-하드록시메틸-2-푸르푸랄을 함유하는 비형 간염 치료제 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR950023404A true KR950023404A (ko) | 1995-08-18 |
KR100285586B1 KR100285586B1 (ko) | 2001-04-02 |
Family
ID=37514432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019940001240A KR100285586B1 (ko) | 1994-01-25 | 1994-01-25 | 5-하드록시메틸-2-푸르푸랄을 함유하는 비형 간염 치료제 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100285586B1 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103202804A (zh) * | 2013-02-22 | 2013-07-17 | 广东先强药业股份有限公司 | 一种单磷酸阿糖腺苷注射液及其制备方法 |
-
1994
- 1994-01-25 KR KR1019940001240A patent/KR100285586B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR100285586B1 (ko) | 2001-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2173328A1 (en) | HIV Protease Inhibitors | |
DE69202207T2 (de) | Verfahren zur Herstellung von 1-Chlor-1,1,3,3,3-Pentafluorpropan und von 1,1,1,3,3,3-Hexafluorpropan. | |
ID21526A (id) | 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus | |
PT93393A (pt) | Processo para a preparacao de vacinas e de agentes de diagnostico que contem regioes imunogenicas de proteina e7do virus do papiloma humano do tipo 16 ou anticorpos suscitados contra estas regioes | |
KR890015742A (ko) | 이병치료용 국소 제제 | |
KR950031060A (ko) | 골다공증 치료용 약제학적 조성물 | |
ES2184764T3 (es) | Complejos de inclusion de taxol o taxotere o extracto de taxus formados por ciclodextrinas, su preparacion y utilizacion. | |
DE69518840D1 (en) | N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren | |
ES2173923T3 (es) | Procedimiento que permite inactivar un virus en presencia de un polieter y de un agente. | |
WO2001097824A3 (de) | Verwendung von phyllanthusbestandteilen zur behandlung oder prophylaxe von infekten durch flaviviridae | |
DE59914712D1 (de) | Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden | |
KR950023404A (ko) | 5-히드록시메틸-2-푸르푸랄을 함유하는 비(b)형 간염 치료제 | |
DE69309790T2 (de) | Cyclopentanperhydrophenanthren-17-beta-(3-Furyl)-3-Derivate und pharmazeutische Präparate davon, zur Behandlung von Kardiovaskulär-Erkrankungen | |
ATE206458T1 (de) | T-zellen stimulierendes protein von pestivirus | |
DE69528044D1 (de) | Synthese von optisch reiner 4-aryl-2-hydroxytetronic | |
KR960006920A (ko) | 혈액 항응고제에 대한 해독제로서 사용하기에 적합한 약제 및 이의 용도 | |
NO900545L (no) | Krydder. | |
KR880009644A (ko) | 궤양성 대장질환 치료용 약한 조성물 | |
WO1988007367A3 (en) | Melatonin-derivatives for psychogenic stress and acute anxiety, and immuno-stimulant drugs | |
KR900015747A (ko) | 간장관련 질병 치료제의 제조방법 | |
DZ1748A1 (fr) | Sel de lysine du 6-chloro-5-fluoro-3-(2-thénoyl)-2-oxindole-1-carboxamide et composition pharmaceutique le contenant. | |
KR950008683A (ko) | 다중약제내성 1 유전자 및 b형 간염바이러스(hbv) 유전자를 발현하는 인체 간암 세포주 | |
KR960006921A (ko) | 약학 조성물 | |
SE9702993D0 (sv) | Anti-mikrobial komposition | |
KR970019821A (ko) | 송진을 함유한 치약 제조 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20031219 Year of fee payment: 4 |
|
LAPS | Lapse due to unpaid annual fee |